Literature DB >> 17923349

Alpers syndrome with prominent white matter changes.

Xinhua Bao1, Ye Wu, Lee-Jun C Wong, Yuehua Zhang, Hui Xiong, Ping-Chieh Chou, Cavatina K Truong, Yuwu Jiang, Jiong Qin, Yun Yuan, Qing Lin, Xiru Wu.   

Abstract

Alpers syndrome is a fatal neurogenetic disorder caused by the mutations in POLG1 gene encoding the mitochondrial DNA polymerase gamma (polgamma). Two missense variants, c.248T > C (p.L83P), c.2662G > A (p.G888S) in POLG1 were detected in a 10-year-old Chinese girl with refractory seizures, acute liver failure after exposure to valproic acid, cortical blindness, and psychomotor regression. The pathology of left occipital lobe showed neuronal loss, spongiform degeneration, astrocytosis, and demyelination. In addition, there were prominent white matter changes in a series of brain magnetic resonance imaging (MRI) and increased immunological factors in CSF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923349     DOI: 10.1016/j.braindev.2007.08.009

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  Palliative functional hemispherectomy for treatment of refractory status epilepticus associated with Alpers' disease.

Authors:  Svetlana Lupashko; Saleem Malik; David Donahue; Angel Hernandez; M Scott Perry
Journal:  Childs Nerv Syst       Date:  2011-06-01       Impact factor: 1.475

2.  POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders.

Authors:  Russell P Saneto; Inn-Chi Lee; Mary Kay Koenig; Xinhua Bao; Shao-Wen Weng; Robert K Naviaux; Lee-Jun C Wong
Journal:  Seizure       Date:  2010-02-06       Impact factor: 3.184

3.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations.

Authors:  Lee-Jun C Wong; Robert K Naviaux; Nicola Brunetti-Pierri; Qing Zhang; Eric S Schmitt; Cavatina Truong; Margherita Milone; Bruce H Cohen; Beverly Wical; Jaya Ganesh; Alice A Basinger; Barbara K Burton; Kathryn Swoboda; Donald L Gilbert; Adeline Vanderver; Russell P Saneto; Bruno Maranda; Georgianne Arnold; Jose E Abdenur; Paula J Waters; William C Copeland
Journal:  Hum Mutat       Date:  2008-09       Impact factor: 4.878

4.  Severe hepatopathy and neurological deterioration after start of valproate treatment in a 6-year-old child with mitochondrial tryptophanyl-tRNA synthetase deficiency.

Authors:  Elise Vantroys; Joél Smet; Arnaud V Vanlander; Sarah Vergult; Ruth De Bruyne; Frank Roels; Hedwig Stepman; Herbert Roeyers; Björn Menten; Rudy Van Coster
Journal:  Orphanet J Rare Dis       Date:  2018-05-21       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.